昭衍新药
(603127)
| 流通市值：267.22亿 | | | 总市值：319.00亿 |
| 流通股本：6.28亿 | | | 总股本：7.49亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 823,935,437.55 | 983,084,920.32 | 911,854,340.56 | 902,060,508.84 |
| 交易性金融资产 | 1,558,415,813.92 | 1,510,896,776.5 | 1,718,323,008.81 | 1,575,189,890.2 |
| 应收票据及应收账款 | 198,150,416.19 | 198,938,127.04 | 196,590,017.22 | 166,857,549.94 |
| 其中：应收票据 | 30,046,510.51 | 15,333,103.05 | 15,461,561.71 | 18,447,865.38 |
| 应收账款 | 168,103,905.68 | 183,605,023.99 | 181,128,455.51 | 148,409,684.56 |
| 预付款项 | 43,843,410 | 54,595,863.19 | 33,422,034.95 | 27,699,486.84 |
| 其他应收款合计 | 4,619,816.07 | 4,793,377.43 | 5,812,482.45 | 6,853,276.25 |
| 存货 | 1,862,244,926.64 | 1,563,000,984.79 | 1,412,250,590.51 | 1,574,086,005.34 |
| 合同资产 | 114,873,056.5 | 116,518,395.23 | 135,919,627.74 | 90,528,150.05 |
| 一年内到期的非流动资产 | 1,850,963,518.83 | 585,703,080.5 | 791,566,765.36 | 914,502,143.91 |
| 其他流动资产 | 45,504,161.69 | 49,774,157.98 | 56,496,858.39 | 55,287,257.8 |
| 流动资产合计 | 6,502,550,557.39 | 5,067,305,682.98 | 5,262,235,725.99 | 5,313,064,269.17 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 80,940,000 | 80,940,000 | 80,940,000 | 91,000,000 |
| 其他非流动金融资产 | 737,834,994.27 | 652,193,468.75 | 639,991,823.45 | 736,418,708.22 |
| 固定资产 | 741,081,536.88 | 750,725,116.49 | 766,679,488.27 | 780,358,583.1 |
| 在建工程 | 292,083,522.61 | 289,528,475.67 | 280,423,945.25 | 293,487,606.81 |
| 生产性生物资产 | 1,322,766,865.59 | 1,096,992,358.23 | 668,392,322.32 | 389,641,354.24 |
| 使用权资产 | 25,535,117.65 | 30,574,392.02 | 16,235,435.55 | 27,073,312.1 |
| 无形资产 | 274,755,787.41 | 279,844,252.79 | 285,054,055.86 | 289,490,170.15 |
| 商誉 | 52,994,821.68 | 53,839,047.57 | 54,690,276.26 | 136,444,900.46 |
| 长期待摊费用 | 65,508,426.84 | 66,003,207.84 | 69,845,167.51 | 66,387,776.99 |
| 递延所得税资产 | 35,858,423.16 | 40,702,013.29 | 39,677,105.69 | 31,759,527.12 |
| 其他非流动资产 | 694,128,625.25 | 1,628,217,840.58 | 1,517,743,275.09 | 1,378,256,500.86 |
| 非流动资产合计 | 4,323,488,121.34 | 4,969,560,173.23 | 4,419,672,895.25 | 4,220,318,440.05 |
| 资产总计 | 10,826,038,678.73 | 10,036,865,856.21 | 9,681,908,621.24 | 9,533,382,709.22 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 51,553,761.73 | 53,330,348.11 | 73,958,454.81 | 54,546,282.68 |
| 应付账款 | 51,553,761.73 | 53,330,348.11 | 73,958,454.81 | 54,546,282.68 |
| 合同负债 | 1,311,625,844.65 | 1,040,999,057.73 | 854,240,187.33 | 978,965,145.04 |
| 应付职工薪酬 | 75,453,582.94 | 64,033,630.32 | 117,605,841.86 | 70,944,497.26 |
| 应交税费 | 20,669,737.94 | 17,641,649.46 | 19,670,519.18 | 10,582,527.29 |
| 其他应付款合计 | 121,192,003.6 | 57,334,828.56 | 71,103,817.12 | 74,967,371.77 |
| 应付股利 | 14,279,424.72 | - | - | - |
| 一年内到期的非流动负债 | 20,325,004.35 | 24,523,051.01 | 20,170,834.97 | 26,995,393.17 |
| 其他流动负债 | 4,550,799.81 | 3,682,017.89 | 3,838,275.43 | 3,472,772.98 |
| 流动负债合计 | 1,605,370,735.02 | 1,261,544,583.08 | 1,160,587,930.7 | 1,220,473,990.19 |
| 非流动负债: | | | | |
| 租赁负债 | 11,894,310.35 | 12,476,137.43 | 1,424,318.98 | 4,535,076.79 |
| 递延收益 | 68,045,206.58 | 70,533,739.2 | 72,738,875.47 | 74,654,484.55 |
| 递延所得税负债 | 165,382,371.01 | 135,188,527.67 | 121,806,335.01 | 112,696,921.01 |
| 非流动负债合计 | 245,321,887.94 | 218,198,404.3 | 195,969,529.46 | 191,886,482.35 |
| 负债合计 | 1,850,692,622.96 | 1,479,742,987.38 | 1,356,557,460.16 | 1,412,360,472.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 749,348,220 | 749,348,220 | 749,477,334 | 749,477,334 |
| 资本公积 | 5,204,109,955.32 | 5,233,607,769.67 | 5,237,665,882.34 | 5,237,665,882.34 |
| 减:库存股 | 191,919,390.64 | 226,382,908.12 | 230,570,134.79 | 230,570,134.79 |
| 其他综合收益 | 17,240,594.51 | 23,609,564.2 | 30,189,277.98 | 42,996,832.56 |
| 盈余公积 | 167,792,770.8 | 167,792,770.8 | 167,792,770.8 | 167,792,770.8 |
| 未分配利润 | 3,028,401,401.74 | 2,608,781,539.31 | 2,370,424,884.73 | 2,153,289,905.21 |
| 归属于母公司股东权益合计 | 8,974,973,551.73 | 8,556,756,955.86 | 8,324,980,015.06 | 8,120,652,590.12 |
| 少数股东权益 | 372,504.04 | 365,912.97 | 371,146.02 | 369,646.56 |
| 股东权益合计 | 8,975,346,055.77 | 8,557,122,868.83 | 8,325,351,161.08 | 8,121,022,236.68 |
| 负债和股东权益合计 | 10,826,038,678.73 | 10,036,865,856.21 | 9,681,908,621.24 | 9,533,382,709.22 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-03-31 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |